MEDICINOVA, INC. Net Income (Loss) Available to Common Stockholders, Basic
MEDICINOVA, INC. (MNOV) reported Net Income (Loss) Available to Common Stockholders, Basic of -$208.00 thousand for the 3-month period ending 2018-12-31, per its 10-K filed 2019-02-13.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2019-02-13
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-12-31 was -$208.00K.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-09-30 was -$6.78M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-06-30 was -$3.14M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for the quarter ending 2018-03-31 was -$4.54M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$9.20M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for fiscal 2013 was -$4.03M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for fiscal 2012 was -$10.96M.
- MEDICINOVA, INC. net income (loss) available to common stockholders, basic for fiscal 2011 was -$17.73M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 3 month as first filed | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month | Net Income (Loss) Available to Common Stockholders, Basic 129 month | Net Income (Loss) Available to Common Stockholders, Basic 132 month | Net Income (Loss) Available to Common Stockholders, Basic 135 month | Net Income (Loss) Available to Common Stockholders, Basic 138 month | Net Income (Loss) Available to Common Stockholders, Basic 141 month | Net Income (Loss) Available to Common Stockholders, Basic 144 month | Net Income (Loss) Available to Common Stockholders, Basic 147 month | Net Income (Loss) Available to Common Stockholders, Basic 150 month | Net Income (Loss) Available to Common Stockholders, Basic 153 month | Net Income (Loss) Available to Common Stockholders, Basic 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-12-31 | -$208.00K 10-K · filed 2019-02-13 | -$6.99M derived: sum of 2 quarters · filed 2019-02-13 | -$10.13M derived: sum of 3 quarters · filed 2019-02-13 | -$14.68M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||||
| 2018-09-30 | -$6.78M 10-K · filed 2019-02-13 | -$9.92M derived: sum of 2 quarters · filed 2019-02-13 | -$14.47M derived: sum of 3 quarters · filed 2019-02-13 | -$16.07M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||||
| 2018-06-30 | -$3.14M 10-K · filed 2019-02-13 | -$7.69M derived: sum of 2 quarters · filed 2019-02-13 | -$9.29M derived: sum of 3 quarters · filed 2019-02-13 | -$13.04M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||||
| 2018-03-31 | -$4.54M 10-K · filed 2019-02-13 | -$6.14M derived: sum of 2 quarters · filed 2019-02-13 | -$9.90M derived: sum of 3 quarters · filed 2019-02-13 | -$12.69M derived: sum of 4 quarters · filed 2019-02-13 | |||||||||||
| 2017-12-31 | -$1.60M 10-K · filed 2019-02-13 | -$1.60K 10-K · filed 2018-02-13 | -$5.36M derived: sum of 2 quarters · filed 2019-02-13 | -$8.15M derived: sum of 3 quarters · filed 2019-02-13 | -$11.16M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||
| 2017-09-30 | -$3.75M 10-K · filed 2019-02-13 | -$3.75K 10-K · filed 2018-02-13 | -$6.54M derived: sum of 2 quarters · filed 2019-02-13 | -$9.56M derived: sum of 3 quarters · filed 2019-02-13 | -$9.56M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||
| 2017-06-30 | -$2.79M 10-K · filed 2019-02-13 | -$2.79K 10-K · filed 2018-02-13 | -$5.81M derived: sum of 2 quarters · filed 2019-02-13 | -$5.81M derived: sum of 3 quarters · filed 2019-02-13 | -$5.81M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||
| 2017-03-31 | -$3.02M 10-K · filed 2019-02-13 | -$3.02K 10-K · filed 2018-02-13 | -$3.02M derived: sum of 2 quarters · filed 2019-02-13 | -$3.02M derived: sum of 3 quarters · filed 2019-02-13 | -$3.02M derived: sum of 4 quarters · filed 2019-02-13 | ||||||||||
| 2016-12-31 | -$1.45K 10-K · filed 2018-02-13 | -$4.29K derived: sum of 2 quarters · filed 2018-02-13 | -$7.48K derived: sum of 3 quarters · filed 2018-02-13 | -$10.87K derived: sum of 4 quarters · filed 2018-02-13 | |||||||||||
| 2016-09-30 | -$2.84K 10-K · filed 2018-02-13 | -$6.04K derived: sum of 2 quarters · filed 2018-02-13 | -$9.42K derived: sum of 3 quarters · filed 2018-02-13 | -$12.15K derived: sum of 4 quarters · filed 2018-02-13 | |||||||||||
| 2016-06-30 | -$3.20K 10-K · filed 2018-02-13 | -$6.58K derived: sum of 2 quarters · filed 2018-02-13 | -$9.32K derived: sum of 3 quarters · filed 2018-02-13 | -$10.92K derived: sum of 4 quarters · filed 2018-02-13 | |||||||||||
| 2016-03-31 | -$3.38K 10-K · filed 2018-02-13 | -$6.12K derived: sum of 2 quarters · filed 2018-02-13 | -$7.72K derived: sum of 3 quarters · filed 2018-02-13 | -$10.01K derived: sum of 4 quarters · filed 2018-02-13 | |||||||||||
| 2015-12-31 | -$2.73K 10-K · filed 2017-02-14 | -$4.34K derived: sum of 2 quarters · filed 2017-02-14 | -$6.63K derived: sum of 3 quarters · filed 2017-02-14 | -$8.85K derived: sum of 4 quarters · filed 2017-02-14 | |||||||||||
| 2015-09-30 | -$1.61K 10-K · filed 2017-02-14 | -$3.90K derived: sum of 2 quarters · filed 2017-02-14 | -$6.11K derived: sum of 3 quarters · filed 2017-02-14 | -$8.49K derived: sum of 4 quarters · filed 2017-02-14 | |||||||||||
| 2015-06-30 | -$2.29K 10-K · filed 2017-02-14 | -$2.29M 10-Q · filed 2015-07-30 | -$4.50M 10-Q · filed 2015-07-30 | -$6.88K derived: sum of 3 quarters · filed 2017-02-14 | -$9.22K derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||
| 2015-03-31 | -$2.21K 10-K · filed 2017-02-14 | -$2.22M 10-Q · filed 2015-05-11 | -$4.60K derived: sum of 2 quarters · filed 2017-02-14 | -$6.94K derived: sum of 3 quarters · filed 2017-02-14 | -$9.06K derived: sum of 4 quarters · filed 2017-02-14 | ||||||||||
| 2014-12-31 | -$2.38K 10-K · filed 2016-02-25 | -$2.38M 10-K · filed 2015-03-12 | -$4.72K derived: sum of 2 quarters · filed 2016-02-25 | -$6.84K derived: sum of 3 quarters · filed 2016-02-25 | -$9.20M 10-K · filed 2015-03-12 | ||||||||||
| 2014-09-30 | -$2.34K 10-K · filed 2016-02-25 | -$2.34M 10-Q · filed 2014-11-13 | -$4.46K derived: sum of 2 quarters · filed 2016-02-25 | -$6.81M 10-Q · filed 2014-11-13 | $3.41M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||
| 2014-06-30 | -$2.12K 10-K · filed 2016-02-25 | -$2.12M 10-Q · filed 2014-08-13 | -$4.47M 10-Q · filed 2015-07-30 | $3.41M derived: sum of 3 quarters · filed 2016-02-25 | $1.17M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||
| 2014-03-31 | -$2.35K 10-K · filed 2016-02-25 | -$2.35M 10-Q · filed 2014-05-08 | $3.41M derived: sum of 2 quarters · filed 2016-02-25 | $1.17M derived: sum of 3 quarters · filed 2016-02-25 | -$1.61M derived: sum of 4 quarters · filed 2016-02-25 | ||||||||||
| 2013-12-31 | $3.41M 10-K · filed 2015-03-12 | $1.18M derived: sum of 2 quarters · filed 2015-03-12 | -$1.61M derived: sum of 3 quarters · filed 2015-03-12 | -$4.03M 10-K · filed 2015-03-12 | |||||||||||
| 2013-09-30 | -$2.24M 10-K · filed 2015-03-12 | -$2.24M 10-Q · filed 2013-11-07 | -$5.02M derived: sum of 2 quarters · filed 2015-03-12 | -$7.44M 10-Q · filed 2014-11-13 | -$9.88M derived: sum of 4 quarters · filed 2015-03-12 | -$303.68M 10-Q · filed 2013-11-07 | |||||||||
| 2013-06-30 | -$2.79M 10-K · filed 2015-03-12 | -$2.79M 10-Q · filed 2013-08-08 | -$5.21M 10-Q · filed 2014-08-13 | -$7.64M derived: sum of 3 quarters · filed 2015-03-12 | -$10.02M derived: sum of 4 quarters · filed 2015-03-12 | -$301.44M 10-Q · filed 2013-08-08 | |||||||||
| 2013-03-31 | -$2.42M 10-K · filed 2015-03-12 | -$2.42M 10-Q · filed 2013-05-08 | -$4.85M derived: sum of 2 quarters · filed 2015-03-12 | -$7.23M derived: sum of 3 quarters · filed 2015-03-12 | -$9.51M derived: sum of 4 quarters · filed 2015-03-12 | -$298.65M 10-Q · filed 2013-05-08 | |||||||||
| 2012-12-31 | -$2.43M 10-K · filed 2014-03-27 | -$4.81M derived: sum of 2 quarters · filed 2014-03-27 | -$7.09M derived: sum of 3 quarters · filed 2014-03-27 | -$10.96M 10-K · filed 2014-03-27 | -$296.23M 10-K · filed 2013-03-28 | ||||||||||
| 2012-09-30 | -$2.38M 10-K · filed 2014-03-27 | -$2.38M 10-Q · filed 2012-11-08 | -$4.66M derived: sum of 2 quarters · filed 2014-03-27 | -$8.53M 10-Q · filed 2013-11-07 | -$12.03M derived: sum of 4 quarters · filed 2014-03-27 | -$293.80M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | -$2.28M 10-K · filed 2014-03-27 | -$2.28M 10-Q · filed 2012-08-09 | -$6.15M 10-Q · filed 2013-08-08 | -$9.65M derived: sum of 3 quarters · filed 2014-03-27 | -$13.54M derived: sum of 4 quarters · filed 2014-03-27 | -$291.42M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | -$3.87M 10-K · filed 2014-03-27 | -$3.87M 10-Q · filed 2012-05-10 | -$7.37M derived: sum of 2 quarters · filed 2014-03-27 | -$11.26M derived: sum of 3 quarters · filed 2014-03-27 | -$15.95M derived: sum of 4 quarters · filed 2014-03-27 | -$289.14M 10-Q · filed 2012-05-10 | |||||||||
| 2011-12-31 | -$3.50M 10-K · filed 2013-03-28 | -$7.40M derived: sum of 2 quarters · filed 2013-03-28 | -$12.08M derived: sum of 3 quarters · filed 2013-03-28 | -$17.73M 10-K · filed 2013-03-28 | -$285.27M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | -$3.89M 10-K · filed 2013-03-28 | -$3.89M 10-Q · filed 2011-11-14 | -$8.57M derived: sum of 2 quarters · filed 2013-03-28 | -$14.23M 10-Q · filed 2012-11-08 | -$19.22M derived: sum of 4 quarters · filed 2013-03-28 | -$281.77M 10-Q · filed 2011-11-14 | |||||||||
| 2011-06-30 | -$4.68M 10-K · filed 2013-03-28 | -$4.68M 10-Q · filed 2011-08-15 | -$10.34M 10-Q · filed 2012-08-09 | -$15.33M derived: sum of 3 quarters · filed 2013-03-28 | -$21.03M derived: sum of 4 quarters · filed 2013-03-28 | -$277.88M 10-Q · filed 2011-08-15 | |||||||||
| 2011-03-31 | -$5.66M 10-K · filed 2013-03-28 | -$5.66M 10-Q · filed 2012-05-10 | -$10.65M derived: sum of 2 quarters · filed 2013-03-28 | -$16.35M derived: sum of 3 quarters · filed 2013-03-28 | -$20.68M derived: sum of 4 quarters · filed 2013-03-28 | ||||||||||
| 2010-12-31 | -$4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-29 | -$10.69M derived: sum of 2 quarters · filed 2012-03-29 | -$15.03M derived: sum of 3 quarters · filed 2012-03-29 | -$20.19M 10-K · filed 2012-03-29 | |||||||||||
| 2010-09-30 | -$5.70M 10-Q · filed 2011-11-14 | -$10.03M derived: sum of 2 quarters · filed 2011-11-14 | -$15.20M 10-Q · filed 2011-11-14 | ||||||||||||
| 2010-06-30 | -$4.33M 10-Q · filed 2011-08-15 | -$9.50M 10-Q · filed 2011-08-15 | |||||||||||||
| 2009-12-31 | -$20.37M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |